(Q33210296)

English

Short-term treatment with rosiglitazone improves glucose tolerance, insulin sensitivity and endothelial function in renal transplant recipients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 July 2017

Short-term treatment with rosiglitazone improves glucose tolerance, insulin sensitivity and endothelial function in renal transplant recipients (English)

1 reference

Europe PubMed Central

23 July 2017

0 references

(RS)-rosiglitazone

1 reference

based on heuristic

inferred from title

author name string

Monica Hagen Voytovich

1

1 reference

Europe PubMed Central

23 July 2017

Cathrine Simonsen

2

1 reference

Europe PubMed Central

23 July 2017

Trond Jenssen

3

1 reference

Europe PubMed Central

23 July 2017

Jøran Hjelmesaeth

4

1 reference

Europe PubMed Central

23 July 2017

Anders Asberg

5

1 reference

Europe PubMed Central

23 July 2017

Anders Hartmann

6

1 reference

Europe PubMed Central

23 July 2017

language of work or name

0 references

publication date

22 December 2004

1 reference

Europe PubMed Central

23 July 2017

Nephrology Dialysis Transplantation

1 reference

Europe PubMed Central

23 July 2017

20

1 reference

Europe PubMed Central

23 July 2017

2

1 reference

Europe PubMed Central

23 July 2017

413-418

1 reference

Europe PubMed Central

23 July 2017

Patient survival after renal transplantation: IV. Impact of post-transplant diabetes

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH641

21 January 2018

Metabolic cardiovascular syndrome after renal transplantation

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH641

21 January 2018

A 6-year prospective study on new onset diabetes mellitus, insulin release and insulin sensitivity in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH641

21 January 2018

Insulin resistance after renal transplantation: impact of immunosuppressive and antihypertensive therapy

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH641

21 January 2018

Endothelial dysfunction in renal transplant recipients maintained on cyclosporine

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH641

21 January 2018

Insulin resistance and endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH641

21 January 2018

Effects of rosiglitazone on endothelial function, C-reactive protein, and components of the metabolic syndrome in nondiabetic patients with the metabolic syndrome.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH641

21 January 2018

Effective use of thiazolidinediones for the treatment of glucocorticoid-induced diabetes

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH641

21 January 2018

Insulin resistance is a common denominator of post-transplant diabetes mellitus and impaired glucose tolerance in renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH641

21 January 2018

Prediction of lean body mass from height and weight

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH641

21 January 2018

Can capillary whole blood glucose and venous plasma glucose measurements be used interchangeably in diagnosis of diabetes mellitus?

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH641

21 January 2018

Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH641

21 January 2018

Nonspecific microvascular vasodilation during iontophoresis is attenuated by application of hyperosmolar saline

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH641

21 January 2018

Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH641

21 January 2018

The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH641

21 January 2018

Rosiglitazone short-term monotherapy lowers fasting and post-prandial glucose in patients with type II diabetes.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH641

21 January 2018

Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH641

21 January 2018

Rosiglitazone treatment of diabetes mellitus after solid organ transplantation

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH641

21 January 2018

Once- and twice-daily dosing with rosiglitazone improves glycemic control in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH641

21 January 2018

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH641

21 January 2018

Identifiers

10.1093/NDT/GFH641

1 reference

Europe PubMed Central

23 July 2017

1 reference

Europe PubMed Central

23 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33210296&oldid=1979146130"